Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Haematologica|September 5, 2007
Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myelomaHeinz Ludwig, Johannes Drach, Helmut Graf, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2008
Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control studyPaul Michielsen, Lothar Heinemann, Michael Mihatsch, et al.BMC Nephrology|August 10, 2005
Case-control study on analgesics and nephropathy (SAN): protocolLothar A J Heinemann, Edeltraut Garbe, Michael Lewis, et al.Expert Opinion on Pharmacotherapy|April 2, 2008
Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograftIrmgard Neumann, Heinz Fuhrmann, Marina Kanzler, et al.Nephron. Clinical Practice|January 25, 2014
Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients: a German-Austrian, single-arm, open-label, prospective, noninterventional, observational studyPatrick Biggar, Josef Kovarik, Renate Klauser-Braun, et al.BMC Nephrology|December 7, 2007
Analgesics use and ESRD in younger age: a case-control studyFokke J van der Woude, Lothar A J Heinemann, Helmut Graf, et al.Wiener Klinische Wochenschrift|January 22, 2011
Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO studyEmanuel Zitt, Christine Jäger, Alexander R Rosenkranz, et al.Nephron. Clinical Practice|April 15, 2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcetMartin Wilkie, Giuseppe Pontoriero, Fernando Macário, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidismPiergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.Pageof 1